Search

Your search keyword '"Spampinato, N."' showing total 234 results
Start Over Author "Spampinato, N."
234 results on '"Spampinato, N."'

8. Ultrafiltrazione e ultradiafiltrazione continua con controllo volumetrico automatizzato nel trattamento dell'insufficienza renale postoperatoria: esperienza in 36 pazienti

Author

MUSUMECI, ANTONINO, MANNACIO, VITO ANTONIO, GAGLIARDI, CESARE, DE AMICIS, VINCENZO, Di Tommaso, L, Caputo, M, Spampinato, N., Musumeci A, Di Tommaso L, Caputo M, Mannacio V, Gagliardi C, De Amicis V, Spampinato N., Musumeci, Antonino, Di Tommaso, L, Caputo, M, Mannacio, VITO ANTONIO, Gagliardi, Cesare, DE AMICIS, Vincenzo, and Spampinato, N.

Published
1995

21. Minimally invasive cardiac surgery

Author

SPAMPINATO N, DE AMICIS, VINCENZO, IORIO D, DI TOMMASO L, ASCIONE R, FIMIANI L., IANNELLI, GABRIELE, Spampinato, N, DE AMICIS, Vincenzo, Iannelli, Gabriele, Iorio, D, DI TOMMASO, L, Ascione, R, and Fimiani, L.

Published
1997

28. Antithrombin III in heart surgery

Author

BUONOCORE G, CENTOFANTI P, OLIVIERO P, SPAMPINATO N., IANNELLI, GABRIELE, Buonocore, G, Centofanti, P, Oliviero, P, Iannelli, Gabriele, and Spampinato, N.

Published
1994

29. [Use of enoximone in the postoperative course of heart surgery]

Author

Ferrara D, Golino A, Notarangelo S, Brando G, Esposito E, Avossa N, Spampinato N., STASSANO, PAOLO, DE AMICIS, VINCENZO, D., Ferrara, A., Golino, S., Notarangelo, Stassano, Paolo, G., Brando, DE AMICIS, Vincenzo, E., Esposito, N., Avossa, N., Spampinato, Ferrara, D, Golino, A, Notarangelo, S, Brando, G, Esposito, E, Avossa, N, and Spampinato, N.

Subjects
Male, Postoperative Care, Dose-Response Relationship, Drug, Hemodynamics, Drug Evaluation, Humans, Female, Vascular Resistance, Cardiac Output, Cardiac Surgical Procedures, Middle Aged, Infusions, Intravenous, Enoximone
Abstract

The aim of this study was to evaluate the efficacy and safety of enoximone, an imidazolonic compound inhibiting cardiac phosphodiesterase III, during the postoperative period. The drug was administered prior to the usual stages of weaning the patient off extracorporeal circulation, to a group of 20 subjects who presented an ejection fraction of less than 35% following hemodynamic studies. Patients were randomly subdivided into 4 groups each of which received a different dose of enoximone according to the following protocol: Group A, 1 mg/kg bolus and slow infusion at 10 gamma/kg/min; Group B, 0.5 mg/kg bolus and slow infusion at 15 gamma/kg/min; Group C, 0.5 mg/kg bolus and slow infusion at 10 gamma/kg/min; Group D, slow infusion at 10 gamma/kg/min. The best results in hemodynamic terms and with regard to the positive inotropic and vasodilatory action of the drug in question were obtained in Group C. Increased cardiac output was observed in all patients within 120 minutes of enoximone administration and reduced systemic vascular resistance after approximately 6 hours of infusion. Special attention should be drawn to the use of the drug in patients who do not respond to conventional therapy due to its mechanism of action which is not dependent on beta receptors, thus enabling good results to be achieved even when these are down regulated. Special care must be taken however in administrating enoximone to platelet-deficient patients since the reduction of platelet levels is one of its collateral effect. Other collateral effects observed were: supraventricular arrhythmias and ventricular tachyarrhythmias.

Published
1993

31. Clinical experience with the transvenous Medtronic Pacer Cardioverter Defibrillator (PCD) System

Author

Golino, A., Pappone, C., Panza, A., Santomauro, M., Iorio, D., Vincenzo DE AMICIS, Chiariello, M., Spampinato, N., Golino, A, Pappone, C, Panza, A, Santomauro, M, Iorio, D, De Amicis, V, Chiariello, M, Spampinato, N, Santomauro, Maurizio, DE AMICIS, Vincenzo, and N., Spampinato

Subjects
Adult, Male, Evaluation Studies as Topic, Tachycardia, Ventricular, Humans, Coronary Disease, Female, Middle Aged, Research Article, Aged, Defibrillators, Implantable, Retrospective Studies
Abstract

We review our experience with the transvenous Medtronic Pacer Cardioverter Defibrillator System (Model 7217B), a multifunction implantable pacer defibrillator combined with a transvenous lead system (Transvene). From April 1991 to October 1992, we implanted this device in 19 consecutive patients (11 men and 8 women; average age, 56.5 years). Nine patients (47.4%), 5 with coronary artery disease and 4 with dilated cardiomyopathy, had an ejection fraction of < 30%. The average operative time was 129 minutes. In 18 patients (94.7%), the transvenous lead system provided effective sensing, pacing, and defibrillation during intraoperative testing. In each of these cases, the defibrillation threshold was less than 18 J. In 1 patient (5.3%), it was necessary to switch to epicardial leads, which were implanted through a left thoracotomy. All patients were extubated in the recovery room. The average hospital stay was 8 days. There was no early mortality or morbidity. During a maximum follow-up period of 17 months (mean, 9.2 months), no sudden death occurred. The implantable system terminated 245 ventricular tachycardia episodes in 14 patients (73.7%) and 82 ventricular fibrillation episodes in 13 patients (68.4%). Two hundred eleven (86.1%) of the ventricular tachycardia episodes were resolved by antitachycardia pacing alone. In 2 patients (10.5%), the caval electrode became dislocated; repositioning of the electrode was followed by repeat defibrillation threshold evaluation. Our experience shows that the transvenous Medtronic Pacer Cardioverter Defibrillator System provides safe, effective treatment of ventricular tachyarrhythmias. Because the perioperative mortality and morbidity are extremely low, use of this device may be particularly beneficial in patients with a high operative risk. Moreover, the lower number of unpleasant therapeutic shocks should increase patient a acceptance of the device.

Published
1993

32. Cross-selectional investigation on the activities of cardiac surgery centers within the 'BPAC project' (short-term outcomes of aortic coronary bypass interventions in italian cardiac surgery)

Author

Seccareccia, F., Capriani, P., Diemoz, S., Taioli, E., Tosti, M. E., Grandjean, J., Chiavarelli, M., Ragni, T., Di Eusanio, G., Staibano, M., Marino, B., Musumeci, F., Chiariello, L., Possati, G. F., Toscano, Michele, Mazzola, A., Gregorini, R., Calafiore, A. M., De Vivo, P., Spampinato, N., Cotrufo, M., Lino, R., Lonobile, T., Di Benedetto, G., Portoghese, M., De Luca Tupputi Schinosa, L., Esposito, L., Curcio, C., Caparotti, S., Villani, M., Roesler, M., Minale, C., Marchese, A. R., Follis, F., Albiero, R., Mazzei, V., Abbate, M., Laudani, G., Gula, G., Ricchi, A., and Martelli, V.

Published
2003

33. Antitachycardiac pacemaker in the control of ventricular tachycardias

Author

Carlo Pappone, Spampinato, N., Lamberti, F., Santomauro, M., Di Pietro, M., Tortoriello, V., Rillo, M., Simone, A., Stabile, G., Salerno, J. A., Chiariello, M., Pappone, C, Spampinato, N, Lamberti, F, Santomauro, M, Di Pietro, M, Tortoriello, V, Rillo, M, De Simone, A, Stabile, G, Salerno, Ja, and Chiariello, M

Published
1992

34. Clinical experience with the internal cardioverter/defibrillator

Author

Zardini, M., Storti, C., Graffigna, A., Carlo Pappone, Lamberti, F., Di Pietro, M., Vigano, M., Spampinato, N., Salerno, J. A., Chiariello, M., Zardini, M, Storti, C, Graffigna, A, Pappone, C, Lamberti, F, Di Pietro, M, Vigano, M, Spampinato, N, Salerno, Ja, and Chiariello, M

Published
1991

35. Tricuspid valve replacement in multiple valve disease

Author

IANNELLI, GABRIELE, PANZA A, GOLINO A, CHELLO M, PETRAZZUOLI F, CIARDIELLO A, DI TOMMASO L, SPAMPINATO N., Iannelli, Gabriele, Panza, A, Golino, A, Chello, M, Petrazzuoli, F, Ciardiello, A, DI TOMMASO, L, and Spampinato, N.

Published
1990

36. Aortic valve replacement through a minimally invasive approach

Author

Vincenzo DE AMICIS, Ascione, R., Iannelli, G., Di Tommaso, L., Monaco, M., Spampinato, N., DE AMICIS, Vincenzo, R., Ascione, Iannelli, Gabriele, Tommaso, L. D., M., Monaco, and N., Spampinato

Subjects
RIGHT ANTEROLATERAL THORACOTOMY, ATRIAL SEPTAL-DEFECT
Abstract

Minimally invasive cardiac surgery is rapidly gaining interest because of fast recovery, reduced morbidity, shorter hospital stay, lower costs, and better cosmetic results. Aortic valve surgery can be performed through a small (10- to 12-cm) transverse sternal incision, and femoro-femoral cannulation is used for cardiopulmonary bypass. Exposure of the ascending aorta is satisfactory From 1 March through 30 September 1996, 7 patients underwent aortic valve replacement through this approach. The mean age of the 5 women and 2 men was 58.8 years. We used this technique mainly in patients with chronic obstructive pulmonary disease, diabetes, or obesity, in the absence of coronary artery disease. There was no mortality, nor was there reoperation for bleeding, stroke or wound infection. All patients were extubated after 2 hours in intensive care and were discharged on the 4th postoperative day. Additional cases are needed to properly assess the correct indication and surgical technique.

Published
1997

37. [The usefulness of bioimpedance in patient monitoring in an intensive-therapy heart-surgery unit: a comparison with thermodilution]

Author

Ferraro S, Michele D'Alto, Maddalena G, Golino A, Liguori L, Jannelli G, Spampinato N, and Chiariello M

Subjects
Adult, Male, Postoperative Care, Critical Care, Thermodilution, Hemodynamics, Middle Aged, Evaluation Studies as Topic, Catheterization, Swan-Ganz, Electric Impedance, Humans, Female, Cardiac Surgical Procedures, Aged, Monitoring, Physiologic
Abstract

Haemodynamic monitoring of intensive care unit (ICU) patients can be carried out by thermodilution system. This method is invasive, does not give a continuous monitoring and complications can occur. Thoracic electrical bioimpedance (TB), a non invasive, fast, easily repeatable method, is able to measure some important haemodynamic parameters: end diastolic volume (EDV), stroke volume, cardiac output (CO), ejection fraction (EF), some contractility indexes, systemic vascular resistances (SVR) and cardiac work. The aim of the present study is to compare CO and SVR obtained by thermodilution with the same indexes obtained by TB. Therefore, 20 ICU patients (12 males and 8 females, mean age 54 +/- 11 years) were studied. Out of them, 16 had been submitted to cardiac surgery in the previous 7 days and 4 were waiting for cardiac surgery. The patients were divided in 2 groups: Group A (N 4) included patients with valvular malfunction and/or cardiac arrhythmias and Group B (N 16) included patients with normal valvular function and sinus rhythm. CO obtained by TB was well related with the one obtained by invasive (INV; r = 0.878; p0.001). The mean value of difference of the 2 methods was 12.29 +/- 11.83 for the whole group of 20 patients but it was 26.07 +/- 14.16 in the Group A and 8.84 +/- 8.09 in the Group B confirming the less reliability of the method in patients with abnormal valvular function or in the presence of cardiac arrhythmias. As a consequence, SVR obtained by TB and INV resulted well related (r = 0.752; p0.001). The mean value of differences was 11.14 +/- 9.01 in the group of 20 patients and particularly 19.55 +/- 10.87 in the Group A and 9.04 +/- 7.07 in the Group B. In a subgroup of 9 patients, CO was measured at successive times (0, 30, 60, 90 min) by both TB and INV; when comparing the 2 CO values a significant correlation was observed. In conclusion, TB represents a valid method in haemodynamic monitoring of the ICU patients.

Published
1993

48. Mid-term results of the valve-on-valve technique for bioprosthetic failure.

Author

Stassano, P, Musumeci, A, Losi, M A, Gagliardi, C, and Spampinato, N

Abstract

Redo operations for bioprosthesis malfunction can sometimes be technically very demanding and cardiac structures may be damaged. Excising only the leaflets of the damaged bioprosthesis and leaving the old ring in situ on which the 'new' mechanical valve is sutured can, in very selected cases, represent a solution.

Published
2000
Full Text
View/download PDF

50. Il by-pass aorto-coronarico con follow-up superiore ai 5 anni

Author

Lino R, Tecchia LB, Bonocore G, Petrazzuoli L, Manzi O, Golino A, Covino E, Spampinato N., PRASTARO, MARIA, VIGORITO, CARLO, Lino, R, Tecchia, Lb, Bonocore, G, Petrazzuoli, L, Prastaro, Maria, Manzi, O, Golino, A, Vigorito, Carlo, Covino, E, and Spampinato, N.

Subjects
follow-up, BPAC, prevenzione secondaria
Published
1985

Catalog

Books, media, physical & digital resources
See catalog results